secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alector, Inc. (ALEC)
CIK:        0001653087
Form:       8-K
Filed at:   2021-09-07T23:59:59+00:00
Accession:  0001193125-21-266663
Event type: leadership
Sentiment:  negative
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alector announces planned departure of President/COO and CMO; appoints interim CMO
--------------------------------------------------------------------------------

- Shehnaaz Suliman (President/COO) to step down; transition through Dec 31, 2021, then advisor.
- Robert Paul (CMO) steps down; will work part-time ($1,730/week) until Oct 31 health benefits, then advisor.
- Sam Jackson, SVP Clinical Sciences, appointed interim CMO effective Sept 7, 2021.
- Both executives will remain as advisors until end of 2021.
- Dr. Suliman joined 2019, Dr. Paul 2016; transitions are voluntary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1653087/000119312521266663/0001193125-21-266663-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1653087/000119312521266663/d331079d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-266663

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer